Colonial Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
32,076
-1,066
| -3% | -$83.4K | 0.37% | 72 |
|
|
2025
Q1 | $2.4M | Buy |
33,142
+463
| +1% | +$33.6K | 0.37% | 69 |
|
|
2024
Q4 | $2.42M | Buy |
32,679
+1,364
| +4% | +$101K | 0.36% | 70 |
|
|
2024
Q3 | $2.07M | Buy |
31,315
+2,661
| +9% | +$176K | 0.32% | 78 |
|
|
2024
Q2 | $2.65M | Buy |
28,654
+2,696
| +10% | +$249K | 0.47% | 60 |
|
|
2024
Q1 | $2.48M | Buy |
25,958
+2,294
| +10% | +$219K | 0.46% | 59 |
|
|
2023
Q4 | $1.8M | Buy |
23,664
+23,539
| +18,831% | +$1.79M | 0.38% | 67 |
|
|
2023
Q3 | $8.66K | Hold |
125
| – | – | ﹤0.01% | 724 |
|
|
2023
Q2 | $11.8K | Sell |
125
-65
| -34% | -$6.13K | ﹤0.01% | 672 |
|
|
2023
Q1 | $15.7K | Buy |
190
+137
| +258% | +$11.3K | ﹤0.01% | 618 |
|
|
2022
Q4 | $3.99K | Buy |
+53
| New | +$3.99K | ﹤0.01% | 776 |
|